REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al.

description

Case Summary

The court issued a USCA Mandate in the case of REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al. The case number is 20-cv-01226. the details of the mandate are not provided.

No timeline activity recorded yet. This page will grow as rulings and filings land.

Key Issues

• • USCA Mandate
• • REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al

smart_toy Juryvine case summary generated from primary court records. How we verify our work.

fact_check

Docket Snapshot

account_balance

Court

D. Del.

District of Delaware · 3rd Circuit · DE

tag

Docket

Not captured

Civil

timeline

Stage

Active litigation

Active

event

Filed

Date unavailable

Not in the available feed

new_releases

Latest Filing

1:20-cv-01226 REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al.

Other · Apr 29, 2026

newspaper

Coverage

1 article

1 source tracked

groups

Participants

1 Defendant, 1 Plaintiff, 1 Related Organization

3 linked entities

gavel

Judge

Not assigned in feed

What the record shows

This case is tied to District of Delaware, a federal district court in DE.

The newest docket activity we have is a other dated April 29, 2026.

The visible party/entity graph currently includes Sarepta Therapeutics, Inc, 1:20-cv-01226 REGENXBIO Inc and others.

Press monitoring has found 1 related article from 1 distinct source.

About This Court

District of Delaware (D. Del.) is a federal district court in the 3rd Circuit, DE.

Case Timeline

1 event

info

Other April 29, 2026

1:20-cv-01226 REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al.

The US Court of Appeals for the Federal Circuit has issued a mandate in the case of REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al. (1:20-cv-01226). This mandate indicates that the appeals court has completed its review of the case and is returning it to the lower court for further action. The mandate is a procedural step that allows the case to move forward.

description View filing open_in_new

newspaper

Press Coverage

1 article

All No paywall (1) Original reporting (1)

newspaper

Coverage

1:20-cv-01226 REGENXBIO Inc. et al v. Sarepta Therapeutics, Inc., et al.

USCA Mandate ( 252

Apr 29, 2026 · 1 min read